April 14, 2022
Article
Pharmacists should review the medications of patients with multiple sclerosis regularly to assess drug-drug interactions.
April 11, 2022
In a clinical trial, 86.4% of patients on semaglutide achieved a 5% weight loss at week 68 compared to 31.5% with placebo.